CoreCap Advisors »

Halozyme Therapeutics shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.4k 5.0k 1.08

More positions owned by CoreCap Advisors

State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard S&p 500 Etf Etf (VOO)
State Street Technology Select Sector Spdr Etf Etf (XLK)
Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Schwab U.s. Small-cap Etf Etf (SCHA)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Ishares Core S&p 500 Etf Etf (IVV)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Growth Etf Etf (VUG)

View all positions for CoreCap Advisors

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation
Ameriprise Financial
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
FMR

View all funds holding Halozyme Therapeutics